long intergenic non-protein coding RNA 557Genealiases: []
Q-omics provides the consensus-scored LINC00557 profile across patient tissues and cancer cell-line models. LINC00557 expression is associated with patient survival in 17 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, LINC00557 is differentially expressed in 4, with the highest sampling consensus in HNSC. Additionally, LINC00557 RNA expression shows 6,671 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight UVM, HNSC, and ESCA as cancer lineages where LINC00557 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00557 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00557 survival associations across molecular data types. LINC00557 RNA expression shows survival associations in the most cancer types (17). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00557 RNA expression–survival associations across cancer types. High LINC00557 expression shows unfavorable associations in UVM, ACC, UCEC and LIHC, but favorable associations in HNSC and LUSC. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for LINC00557 RNA expression.
This table summarizes LINC00557 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00557. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00557 shows higher tumor expression in HNSC, LUSC, KIRC and KICH. The HNSC box plot shows higher LINC00557 RNA expression in tumor versus normal tissue (log2 FC = +0.055, t-test p = .007).
This table shows molecular features associated with LINC00557 in patient tissues and cancer cell lines. In patient samples, LINC00557 shows the broadest associations at the RNA and protein expression levels, with ESCA recurring as the lineage with the largest associated feature set.
